Weight-loss drugs are becoming a popular employee perk, with almost a third of workers saying they’d switch jobs to get GLP-1 coverage. Weight loss drugs are popular—but 60% of firms only offer it for diabetesIn the past couple of years, weight loss drugs like Ozempic, Wegovy, and Zepbound have exploded on the wellness market. Around 11% of U.S. adults currently take GLP-1 medications for weight loss purposes, a stark jump from 3% just two years ago, according to a recent Gallup analysis. Around 11% of these big employers have dropped—or are planning to drop—coverage of the drugs for weight-loss purposes this year or next. Health services company Cigna stopped covering GLP-1 weight-loss drugs including Wegovy and Zepbound in its employee health plan this July.